OTCMKTS:GENTY - Gentium Srl Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$56.10 0.00 (0.00 %)
(As of 06/20/2018 07:12 AM ET)
Previous Close$56.10
Today's RangeN/A
52-Week Range$7.26 - $59.25
VolumeN/A
Average Volume6,528 shs
Market Capitalization$872.64 million
P/E RatioN/A
Dividend YieldN/A
Beta1.58
Gentium Srl logoGentium SpA is a biopharmaceutical company focused on the development and manufacture of its product candidate, defibrotide, an investigational drug based on a mixture of single-stranded and double-stranded deoxyribonucleic acid (DNA) extracted from pig intestines. The Company's development of defibrotide has been focused on the treatment and prevention of a disease called hepatic veno-occlusive disease ( VOD), a condition that occurs when veins in the liver are blocked as a result of cancer treatments, such as chemotherapy or radiation, that are administered prior to stem cell transplantation. In February 2014, Jazz Pharmaceuticals PLC acquired the 98% interest in Gentium SpA (Gentium).

Receive GENTY News and Ratings via Email

Sign-up to receive the latest news and ratings for GENTY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolOTCMKTS:GENTY
CUSIPN/A
Phone+39-31-5373200

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

Gentium Srl (OTCMKTS:GENTY) Frequently Asked Questions

What is Gentium Srl's stock symbol?

Gentium Srl trades on the OTCMKTS under the ticker symbol "GENTY."

Who are Gentium Srl's key executives?

Gentium Srl's management team includes the folowing people:
  • Khalid Islam Ph.D., Chairman of the Board, Chief Executive Officer, Interim Scientific Director (Age 61)
  • Salvatore Calabrese, Chief Financial Officer, Chief Operating Officer (Age 44)
  • Carin Heringa, Senior Vice President, Scientific Director (Age 52)
  • Marco Maria Brughera, Director (Age 60)
  • Laura Ferro Ph.D., Director (Age 62)
  • Gigliola Bertoglio CPA, Independent Director (Age 79)
  • Bobby W. Sandage Jr., Ph.D., Independent Director (Age 63)
  • Elmar J. Schnee, Independent Director (Age 57)

Has Gentium Srl been receiving favorable news coverage?

News stories about GENTY stock have been trending positive this week, Accern Sentiment Analysis reports. The research firm ranks the sentiment of press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Gentium Srl earned a news sentiment score of 0.30 on Accern's scale. They also gave press coverage about the biopharmaceutical company an impact score of 45.87 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

How do I buy shares of Gentium Srl?

Shares of GENTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Gentium Srl's stock price today?

One share of GENTY stock can currently be purchased for approximately $56.10.

How big of a company is Gentium Srl?

Gentium Srl has a market capitalization of $872.64 million.

How can I contact Gentium Srl?

Gentium Srl's mailing address is Piazza XX Settembre, 2, VILLA GUARDIA, 22079, Italy. The biopharmaceutical company can be reached via phone at +39-31-5373200.


MarketBeat Community Rating for Gentium Srl (GENTY)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  81 (Vote Outperform)
Underperform Votes:  44 (Vote Underperform)
Total Votes:  125
MarketBeat's community ratings are surveys of what our community members think about Gentium Srl and other stocks. Vote "Outperform" if you believe GENTY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GENTY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.